Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: RNA disruption indicates CHOP therapy efficacy in canine lymphoma

Fig. 1

RNA disruption during CHOP therapy for dogs separated by immunophenotype. RNA disruption during CHOP therapy for dogs separated by immunophenotype A) dogs that had B cell lymphoma (n = 19) and B) dogs that had T cell lymphoma (n = 4). Five dogs were found to have inadequate samples at all time-points and were therefore not included; 13 dogs did not have their tumour immunophenotype determined. Each line represents an individual animal

Back to article page